AI assistant
Sending…
PAVmed Inc. — Director's Dealing 2016
Nov 23, 2016
35221_dirs_2016-11-23_464f3b64-50f9-47f8-8969-ea4fdc9352cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-11-22
Reporting Person: Lamstein Joshua R (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-22 | Warrants | $5.00 | P | 100 | Acquired | 2022-01-29 | Common Stock (100) | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants | $5.00 | 2022-01-29 | Common Stock (83617) | 83617 | Direct |
More from PAVmed Inc.
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 1
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Feb 24
Regulatory Filings
2026
Feb 17
Capital/Financing Update
2026
Feb 4
Regulatory Filings
2026
Jan 23